TCR-engineered T Cells in NSCLC and HNSCC Patients (ACTengine)

Conditions:   Solid Tumor;   Cancer;   Head and Neck Squamous Cell Carcinoma;   Squamous Cell Non-small Cell Lung Cancer
Interventions:   Biological: IMA201 T-Cells;   Diagnostic Test: IMA201_Detect;   Diagnostic Test: ACT-HLA;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: Recombinant human interleukin-2
Sponsors:   Immatics US, Inc.;   M.D. Anderson Cancer Center
Not yet recruiting - verified August 2017

http://ift.tt/2uNCh9K